STOCK TITAN

Puma Biotechnology Inc (PBYI) Revenue by Year

PBYI

Puma Biotechnology Inc generated $228.4M in revenue in fiscal year 2025. This represents a decrease of 0.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $231.2M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Puma Biotechnology Inc has filed alongside them.

FY2025 annual
Revenue $228.4M
YoY -0.9%
5Y CAGR +0.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PBYI Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$231.2M$228.4M-0.9%$230.5M-2.2%$235.6M+3.3%$228.0M-9.9%$253.2M+12.5%$225.1M-17.3%$272.3M+8.5%$251.0M+806.6%$27.7MN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

PBYI Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$56.5M+7.8%$44.8M-2.6%$75.5M+27.7%$54.5M-32.4%$52.4M+11.4%$46.0M+5.1%$59.1M-18.2%$80.5M+43.5%$47.1M-13.7%$43.8M-17.1%$72.2M+9.9%$56.1M-1.7%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Puma Biotechnology Inc financials

Frequently Asked Questions

What was Puma Biotechnology Inc's revenue in fiscal year 2025?

Puma Biotechnology Inc generated $228.4M in revenue in fiscal year 2025.

How fast is Puma Biotechnology Inc's revenue growing?

Puma Biotechnology Inc (PBYI) revenue fell by 0.9% year over year, from $230.5M to $228.4M in fiscal year 2025.

What is Puma Biotechnology Inc's revenue over the last twelve months?

Puma Biotechnology Inc (PBYI) reported $231.2M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Puma Biotechnology Inc (PBYI) reported $56.5M in revenue in Q2 2026. This represents an increase of 7.8% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Puma Biotechnology Inc (PBYI) reported on that line in every period on record.